MiNK Therapeutics, Inc. (INKT) at a glance

MiNK Therapeutics, Inc. (INKT) is a micro-cap Healthcare company. It trades at $11.04, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (26/100).

Price
$11.05
Market cap
$59.9M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$8.48 to $22.34
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
66
Momentum
26

Other Healthcare stocks

See all